2008-10-01 23:43:02 -
www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/research/fac20b/the_eighth_annual) has announced the addition of the "The Eighth Annual Neurotech Leaders Forum" conference to their offering.
Eighth Annual Neurotech Leaders Forum
Radisson Hotel San Francisco Airport, Brisbane, CA
This two-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are actively
working to grow this new and exciting industry. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neurotechnology industry and the investment community.
Sessions will cover a range of technologies and market segments in the neuro space, including neuromodulation, neural prostheses, neurodiagnostics, and neurostimulation. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as cochlear implants, stroke rehabilitation devices, implanted pain stimulators, neural-computer interfaces, and advanced brain sensing technologies.
The first day of the conference features four intensive courses for neurotechnology professionals, one devoted to fundamentals of the technology, another to neurotechnology market fundamentals, a third to neuropharmaceutical therapies, and a fourth to obtaining venture capital financing.
The second day of the conference features a keynote address by a leading figure in the neurotechnology field. There will also be panel discussions on key issues affecting the industry, such as reimbursement issues, licensing, and other commercialization factors. The conference will wrap up with a panel discussion featuring representatives of some of the leading venture capital firms active in the neuro space. The panelists will discuss critical issues such as the relative strengths and weaknesses of devices and bio/pharma approaches to neurological disorders, the current investment climate in the neuro space, and factors in obtaining funding for neurotechnology startups.
The forum will also feature presentations from several early-stage neurotechnology firms covering a range of product and technology areas. A preliminary agenda for this year's event is available. -0- Who Should Attend: - Neurotechnology Executives - Venture Capital Professionals - Entrepreneurs - Healthcare Professionals - Neural Engineering Researchers
Tentative Agenda
- Day One: Neurotech Basics
The first day of the 2008 event is devoted to basic information about the neurotechnology industry, targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. Conference faculty will offer a detailed background on the basics of the neurotechnolgy industry. The afternoon offers a novel session on neuropharmaceutical therapies and concludes with a panel discussion of issues affecting end users in the neurological disorders community.
8:30-9:00 Registration and Coffee
9:00-10:30 Obtaining Venture Capital Financing
Glenn Cornett, Ph.D, M.D., Senior Financial Editor, Neurotech Reports
This session offers specific and practical advice on preparing a set of initial materials, including executive summary, investor presentation, and financial model, that will attract attention from venture capital firms. It includes examples of items that have made the difference between funding and no funding decisions. The presenter will also discuss how to find the most appropriate VC firm and how to arrange a meeting with the key person at the firm.
10:30-10:45 Refreshment Break
10:45-12:00 Neurotechnology Market Overview
James Cavuoto, Editor and Publisher, Neurotech Reports
This session gives attendees an overview of the neurotechnology device market, with discussion of overall size, market segments, growth rates, competition, and key players. It will also include discussion of the various markets for neurological diseases and disorders.
12:00-1:15 Luncheon
1:15-1:45 Keynote Address
Paul Stypulkowski, Ph.D. Senior Director, Emerging Therapies Research, Medtronic Neuromodulation
1:45-3:00 Neuroengineering History and Basics
Daniel DiLorenzo, M.D., Ph.D., President, DiLorenzo Biomedical
In this session, Dan DiLorenzo, a leading expert on neurotechnology, will present a tutorial on the fundamentals of neurostimulation, neuromodulation, deep-brain stimulation, and related topics. The tutorial will begin with a history of neurostimulation and explain how neurotech devices work, and include a discussion of product features, stimulation parameters, targeted locations.
3:00-3:15 Refreshment Break
3:15-4:15 Fundamentals of Neuroengineering
Dominique Durand, Ph.D., Professor of Biomedical Engineering, Case Western Reserve University
In this session, Dominique Durand provides attendees with a background of basic concepts of neural engineering and neural interfacing. The session includes an explanation of how biological components and electrodes interact at the neural interface, as well as a discussion of key applications in neural prosthetics, brain-computer interfaces, and neuromodulation devices.
4:15-5:00 Physical Therapy/Occupational Therapy Panel
Jennifer French, Executive Director, Neurotech Network, Moderator
This panel will bring together practicing clinicians with leaders in the neurotechnology industry. Discussion topics will be directed at the barriers of acceptance for neurotechnology in clinical practice. Such topics will include concerns of safety and compliance to the patient, financial access, and technology education.
5:00-7:00 Cocktail Reception
- Day Two: Neurotech Industry Sessions
The second day of the conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to grow this new industry.
8:30-9:00 Registration and Coffee
9:00-9:15 Introduction
9:15-10:15 Neurotechnology Industry Update
James Cavuoto, Editor and Publisher, Neurotech Reports
This session will provide attendees with an up-to-date look at the neurotechnology industry, including discussion of deals, merger and acquisition activity, and venture capital funding that has occurred in the last year.
10:15-10:30 Coffee Break, sponsored by BalSeal Engineering
10:30-11:15 Neuromodulation Industry Issues
Bruce Jenett, Partner, DLA Piper US, Moderator
Elliot Krames, M.D., President, International Neuromodulation Society
Daniel Chao, M.D., Director of Business Development, Neuropace Inc.
This session will cover many of the key issues facing the neuromodulation devices industry today, including reimbursement problems, distribution strategies, and the product approval process.
11:15-12:15 Technology Transfer Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Geoff Thrope, President and CEO, NDI Medical Inc.
Janu Jung, Ph.D., Director, Center for Adaptive Neural Systems, Arizona State University
Gail Schechter, Ph.D., Director, Center for BioEntrepreneurship, University of California, San Francisco
This session looks at issues involved with spinning off neurotech startups from academic and clinical research laboratories. Panelists will offer examples of successful spinoffs and debate the advantages and disadvantages of alternative incentive, licensing, and financing options.
12:15-1:30 Luncheon
Presentation of 2008 Gold Electrode Awards
1:30-3:00 Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Vikram Jung, Co-founder, Advensys LLC
Keith Checca, Texcel Medical
Jeff Hendricks, Ph.D., Founder, Biotectix LLC
Alvaro Fernandez, President and CEO, Sharpbrains
David Hawks, Business Development Manager, Invibio Inc.
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.
3:00-3:15 Refreshment Break, Sponsored by Greatbatch, Inc.
3:15-4:00 New Applications Panel
Dominique Durand, Ph.D., Professor of Biomedical Engineering,
Case Western Reserve University
Ben Pless, Ph.D., President, Autonomic Technologies, Inc.
Todd Whitehurst, M.D., Vice-President, Emerging Indications, Boston Scientific Neuromodulation
This session looks at several new application areas emerging in neurotechnology and explores the commercialization potential of each. New technologies covered include optical stimulation, new neurosensing techniques, magnetic stimulation, and slow-wave stimulation.
4:00-5:00 Investment Panel
Glenn Cornett, Ph.D., M.D., Senior Financial Editor, Neurotech Reports, Moderator
Karen Boezi, Partner, Thomas McNerney & Partners
Robert Abrams, Operating Partner, Sanderling Ventures
Peter Fair, Triple Point Capital
Leslie Bottorff, General Partner, ONSET Ventures
In this wrap-up session, representatives from several key venture capital firms in the life sciences space will offer their feedback on the status of the neurotechnology industry and their impressions of the issues discussed during the day.
5:00-7:00 Cocktail Reception
Please note this price includes the conference only and does not include additions such as the hotel fee
For more information visit
www.researchandmarkets.com/research/fac20b/the_eighth_annual
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax (USA): 646-607-1907
Fax (International): +353-1-481-1716
